Biohaven PE Ratio 2016-2023 | BHVN
Current and historical p/e ratio for Biohaven (BHVN) from 2016 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Biohaven PE ratio as of June 02, 2023 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Biohaven PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2023-06-02 |
21.72 |
|
0.00 |
| 2023-03-31 |
13.66 |
$-12.31 |
0.00 |
| 2022-12-31 |
13.88 |
$-14.25 |
0.00 |
| 2022-09-30 |
151.17 |
$-13.94 |
0.00 |
| 2022-06-30 |
145.71 |
$-14.82 |
0.00 |
| 2022-03-31 |
118.57 |
$-11.84 |
0.00 |
| 2021-12-31 |
137.81 |
$-13.08 |
0.00 |
| 2021-09-30 |
138.91 |
$-13.69 |
0.00 |
| 2021-06-30 |
97.08 |
$-14.33 |
0.00 |
| 2021-03-31 |
68.35 |
$-14.18 |
0.00 |
| 2020-12-31 |
85.71 |
$-13.04 |
0.00 |
| 2020-09-30 |
65.01 |
$-12.27 |
0.00 |
| 2020-06-30 |
73.11 |
$-11.04 |
0.00 |
| 2020-03-31 |
34.03 |
$-12.63 |
0.00 |
| 2019-12-31 |
54.44 |
$-10.97 |
0.00 |
| 2019-09-30 |
41.72 |
$-9.46 |
0.00 |
| 2019-06-30 |
43.79 |
$-8.95 |
0.00 |
| 2019-03-31 |
51.47 |
$-5.29 |
0.00 |
| 2018-12-31 |
36.98 |
$-6.20 |
0.00 |
| 2018-09-30 |
37.55 |
$-5.61 |
0.00 |
| 2018-06-30 |
39.52 |
$-5.27 |
0.00 |
| 2018-03-31 |
25.76 |
$-6.04 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.482B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
